Oliveras, A, Vázquez, S, Vega, MV, Camps, C, Illana, FJ, Armario, P, Crespo, M, de la Sierra, A. Improvement of non-adherence and reduction of BP values in patients with difficult-to-treat hypertension: the ATHAN clinical trial. HYPERTENSION RESEARCH. 2024; DOI:10.1038/s41440-024-01748-x. PMID:39085464. IF:4.600(Q1/2D).

Delgado-Lista, J, Mostaza, JM, Arrobas-Velilla, T, Blanco-Vaca, F, Masana, L, Pedro-Botet, J, Perez-Martinez, P, Civeira, F, Cuende-Melero, JI, Gomez-Barrado, JJ, Lahoz, C, Pinto, X, Suarez-Tembra, M, Lopez-Miranda, J, Guijarro, C. Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice. Clinica E Investigacion En Arteriosclerosis. 2024; 36(4)DOI:10.1016/j.arteri.2024.03.002. PMID:38599943. IF:(Q/D).

La Lhoëst, MTL, Martinez, A, Claudi, L, Garcia, E, Benitez-Amaro, A, Polishchuk, A, Piñero, J, Vilades, D, Guerra, JM, Sanz, F, Rotllan, N, Escolà-Gil, JC, Llorente-Cortés, V. Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis. Frontiers in Cardiovascular Medicine. 2024; 11DOI:10.3389/fcvm.2024.1381520. PMID:38952543. IF:2.900(Q2/4D).

Rotllan, N, Escolà-Gil, JC. Apolipoproteins and Lipoproteins in Health and Disease 2.0. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(11)DOI:10.3390/ijms25116183. PMID:38892369. IF:4.900(Q1/3D).

Illana, FJ, García-Osuna, A, Sospedra, M, Ferrer, R, Martínez-Brú, C, Guiñón, L. Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes. Biochemia Medica. 2024; 34(2)DOI:10.11613/BM.2024.020704. PMID:38665870. IF:1.800(Q3/6D).

Lhoëst, MTL, Samouillan, V, García, E, Amaro, AB, Dandurand, J, Dato, VA, Guerra, JM, Escolà-Gil, JC, Chiabrando, G, Enrich, C. Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).